13F
中

AVTX AVALO THERAPEUTICS INC

2026Q1 · CUSIP 05338F306 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
96
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
43
Δ whales
+6
Inst. holding value
$461M
New positions
33
Closed positions
21
Price momentum (1Q)
+7.2%
Put / Call
3/9

Breadth history (34 quarters)

2024Q1: Δ+6 · h=19 2024Q2: Δ+2 · h=21 2024Q3: Δ+9 · h=30 2024Q4: Δ+4 · h=34 2025Q1: Δ+1 · h=35 2025Q2: Δ+1 · h=36 2025Q3: Δ+30 · h=66 2025Q4: Δ+18 · h=84 2026Q1: Δ+12 · h=96 2024Q1: holders=19 2024Q2: holders=21 2024Q3: holders=30 2024Q4: holders=34 2025Q1: holders=35 2025Q2: holders=36 2025Q3: holders=66 2025Q4: holders=84 2026Q1: holders=96 -30 -15 +0 +15 +30 1759101 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 10% -5.4% -3.5%

Options Sentiment

Put holders
3
QoQ: 0
Call holders
9
QoQ: +3

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-6.20
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-03-31: EPS -1.18 2022-06-30: EPS -0.69 2022-09-30: EPS 0.17 2024-06-30: EPS -7.04 2024-09-30: EPS -1.42 2025-03-31: EPS -0.62 2025-06-30: EPS -0.96 2025-09-30: EPS -2.19 2025-12-31: EPS -2.06 2026-03-31: EPS -0.98 -7.74 -3.78 0.19 2022202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)